"I am delighted that Braden has joined the partnership of our Growth Buyout Fund," said David J. Brailer, MD, PhD, Managing Partner and Chief Executive Officer of Health Evolution Partners. "We value his private equity and investment experience and look forward to his leadership on investment opportunities and with our portfolio companies."
Prior to joining Health Evolution Partners, Kelly served as a partner and managing director of General Atlantic LLC, a global private equity investment firm with $18 billion under management. At General Atlantic, Kelly originated and managed its global health care practice, founded the firm's Silicon Valley office, and served on its investment committee. During his 12-year tenure with General Atlantic, Kelly managed investments in the U.S., Europe and India. Prior to General Atlantic, Kelly was an investment banker specializing in mergers, acquisitions and restructurings at Morgan Stanley. Kelly earned a bachelor's degree, summa cum laude, in finance and business economics from the University of Notre Dame.
"Through my relationship with Health Evolution Partners, I have been privileged to work with a great group of talented people and an innovative and strong collection of companies delivering value across the health care landscape," said Kelly. "I am excited to begin a new chapter with the team."